LSE:JMH

Jardine Matheson stock slides 2.4% into weekend — what investors watch before SGX reopens

Jardine Matheson shares dropped 2.4% to US$75.71 in Singapore Friday, with 293,900 shares traded. The Straits Times Index fell 0.8%, ending a three-day record streak. Indonesian stocks and the rupiah also slid after Moody’s cut the country’s credit outlook. Jardine’s full-year results are due March 10.

8 February 2026

LSE:JMH·Stock Market

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

Jardine Matheson fell 2.4% to $75.71 in Singapore Friday, with 293,900 shares traded, as Asia stocks slid on a tech-led selloff. Singapore’s market dropped 0.8%. Investors await Jardine’s full-year results due March 10. Broader market caution follows turbulence in U.S. tech and regional political headlines.

7 February 2026

LSE:JMH·Stock Market

Jardine Matheson stock nudges higher near 52-week peak after buyback, director deal

Jardine Matheson shares rose 0.98% to $77.38 in Singapore on Thursday, nearing their 52-week high after the company disclosed a buyback of 45,000 shares for cancellation and a director’s purchase of 7,000 shares at $73.73 each. Full-year results are due March 10.

5 February 2026

LSE:JMH·Share Buyback·Stock Market

Jardine Matheson Holdings Limited stock price: Buyback and insider buying set up the next trade

Jardine Matheson closed down 0.6% at US$72.77 in Singapore Friday after disclosing a 60,000-share buyback and a director’s US$1 million stock purchase. The company will cancel the repurchased shares, reducing issued capital to about 294.5 million. Full-year results are due March 10.

1 February 2026

LSE:JMH·Share Buybacks·Stock Market

Jardine Matheson stock hits 52-week high on SGX after fresh buyback filing

Jardine Matheson shares rose 2.5% to $76.64 in Singapore Tuesday, hitting a 52-week high after the company repurchased 50,000 shares for about $3.7 million. The Straits Times Index also set a record at 4,912.46. Investors await the U.S. Federal Reserve’s rate decision Wednesday and the Monetary Authority of Singapore’s policy update Thursday.

27 January 2026

LSE:JMH·Stock Market

Jardine Matheson share price edges lower as buybacks roll on, MAS decision next

Jardine Matheson shares slipped 0.1% to US$74.71 in Singapore trading Monday after a filing showed the company bought back 112,700 shares at nearly the same price on Jan. 23. Traders are watching for Singapore’s central bank policy review on Jan. 29 and Jardine’s March earnings.

26 January 2026

LSE:JMH·Stock Market

Jardine Matheson share price stays near $75 on buyback filings as Monday trade looms

Jardine Matheson shares closed at $74.77 in Singapore on Friday, up 0.2%, after the company disclosed buybacks of 112,700 shares on Jan. 23 and 50,000 shares on Jan. 22, all for cancellation. The repurchases are part of a $250 million program set to run through 2026. Markets are closed for the weekend and will reopen Monday.

24 January 2026

LSE:JMH·SGX:J36·Share Buybacks·Stock Market

Jardine Matheson stock price near 52-week high as buybacks stack up and Mandarin Oriental delisting nears

Jardine Matheson shares closed Friday at US$74.35 in Singapore, up 0.22%, after the company repurchased 25,000 shares for cancellation. Two directors disclosed new share acquisitions. Mandarin Oriental’s delisting is set for Jan. 20 following court approval of its privatisation. About 229,200 Jardine shares traded during the session.

17 January 2026

LSE:JMH·Share Buybacks·Stock Market

Singapore Stocks Outlook: 10 Things to Know Before the SGX Opens on 25 November 2025

Singapore’s Straits Times Index rose 0.6% to 4,496.63 on Monday, staying close to its all-time high after the government nearly doubled its 2025 GDP growth forecast to around 4%. Jardine Matheson jumped 8.7%, while Singapore Exchange fell 1.1%. Turnover reached S$3.2 billion. Investors are watching for follow-through as global markets rebound on hopes of a US Fed rate cut.

24 November 2025

LSE:JMH·SGX:D05·SGX:O39·SGX:S68·SGX:U11·Singapore Stocks

Biotech with $277M Cash Says It Can Fund Operations Through 2028
April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026

LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:57 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,

US Stock Market Today After Hours: Nasdaq Hit by AI Worries as Visa, Starbucks and Chip Stocks Jump

29 April 2026

U.S. stocks fell Tuesday, with the Nasdaq down 0.9% as AI and chip shares sold off ahead of major tech earnings. Oracle dropped 4.1%, Nvidia and AMD lost over 1.6%, and CoreWeave slid 5.8%. After hours, Visa and Starbucks rose on strong results and forecasts. Oil prices climbed, and traders watched the Federal Reserve’s rate decision.

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026

AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.

LSE:JMH 24 November 2025 - 8 February 2026

Jardine Matheson stock slides 2.4% into weekend — what investors watch before SGX reopens

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

Jardine Matheson stock hits 52-week high on SGX after fresh buyback filing

Jardine Matheson share price edges lower as buybacks roll on, MAS decision next

Singapore Stocks Outlook: 10 Things to Know Before the SGX Opens on 25 November 2025

Stock Market Today

Latest article

US Stock Market Today: Live Updates 29.04.2026

US Stock Market Today After Hours: Nasdaq Hit by AI Worries as Visa, Starbucks and Chip Stocks Jump

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality